Spain is forecast to have by far the biggest increase in ‘pharma growth potential’ of any country in 2024 [in year of when most countries prospects declined slightly], with Barcelona identified as Europe’s second-best hub for biotech investment, according to the CPHI Annual Report. As more and more international biotech startups and companies are sett...